10 results
DEF 14A
XLO
Xilio Therapeutics Inc
26 Apr 22
Definitive proxy
4:05pm
on our proxy card for the next annual meeting.
Director Independence
Under the listing rules of The Nasdaq Stock Market, or Nasdaq, independent … with the exercise of independent judgment in carrying out the responsibilities of a director.
Audit committee members must also satisfy the independence
10-K
2021 FY
XLO
Xilio Therapeutics Inc
1 Mar 22
Annual report
4:07pm
is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required … ” and “Board Determination of Independence” in our definitive proxy statement for our 2022 Annual Meeting of Stockholders to be filed with the SEC within
424B4
t1twhzva5ugq
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
y1oxd10ii3r62e7j4f7
18 Oct 21
IPO registration (amended)
6:04am
S-1
pypn1iecppyyw 9r
1 Oct 21
IPO registration
4:49pm
DRS/A
lx9rop2aui8r1wfja
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
pgp3e4uefw254d 7yep
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next